Avricore Health Amends Options

Author's Avatar
Sep 11, 2020
Article's Main Image

VANCOUVER, British Columbia, Sept. 10, 2020 (GLOBE NEWSWIRE) -- Avricore Health Inc. (TSXV: AVCR) (the "Company" or “Avricore”) announces that its Board of Directors and Shareholders have approved (subject to TSXV approval) the re-pricing of a total of 2,091,072 options to purchase common shares ("Options") to an amended exercise price of $0.10 per Option (the "Re-Pricing").